MediLink is our proprietary plug-and-play platform for the development of precision immune therapeutics. By seamlessly integrating target-specific antibodies with engineered cytokines, the platform enables the development of novel therapeutic modalities with programmable biological functions.
This modular approach allows rapid exploration of multiple therapeutic designs while achieving enhanced specificity, optimized pharmacology, and controlled immune activity. Through precise regulation of immune pathways, MediLink unlocks broad opportunities across cancer, autoimmune, and inflammatory diseases.
MediKine™ is MMB’s proprietary engineered cytokine platform designed to optimize cytokine activity, improve safety, and extend therapeutic durability. By precisely controlling the strength, duration, and quality of cytokine signaling, MediKine™ enables targeted immune modulation with an improved therapeutic window.
